Europe
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, announced that it established a Scientific Advisory Board for its Corporate Research activities.
Evotec SE announced plans to extend its sample management activities through an expansion of its service agreement with Sanofi.
MC2 Therapeutics announced that its EU Phase 3 trial on the company’s investigational drug, Wynzora™ Cream, met its primary endpoint and that a Marketing Authorization Application is now in preparation for H1 2020.
Genomill Health closes a financing round led by a deep tech VC Voima Ventures to expand its novel and disruptive technology, focusing on efficient use of NGS in liquid biopsies for cancer diagnostics.
Xenikos B.V. announced that the first patient has been treated in their U.S.-based Phase 3 registration trial designed to evaluate the use of T-Guard for treating steroid-refractory acute graft-versus-host disease in patients following allogeneic stem cell transplantation.
Vaccitech Ltd announced that its strategic collaboration with the Ludwig Institute for Cancer Research, Vaccitech Oncology Limited, has entered into a clinical partnership with Cancer Research UK to develop VOLT’s VTP-600 immunotherapy as a treatment option for patients with non-small cell lung cancer.
Pharma, biotech and life sciences organizations strengthen their leadership teams and boards.
What they found was that melanoma cells are more likely to metastasize through the body if their cells have high concentrations of MCT1 on their cell surface.
Adocia, a clinical stage biopharmaceutical company focused on diabetes treatment and other metabolic diseases with innovative formulations of approved proteins, announced its financial calendar for 2020.
Atlantic Healthcare plc, a specialist pharmaceutical company focused on acquiring, developing and commercialising therapeutics that address unmet patient needs and rare diseases, announces it will present at the Biotech Showcase conference, held in San Francisco from January 13-15, 2020.
PRESS RELEASES